Less intensive chemo avoids irreversible side effects in children’s cancer
Children with a rare type of cancer called Wilms’ tumour who are at low risk of relapsing can now be given less intensive treatment, avoiding a type of chemotherapy that can cause irreversible heart problems in later life. The move follows the results of a Cancer Research UK trial showing that the drug doxorubicin can be safely omitted from treatment without affecting patients’ chances of survival.
Lunatic Laboratories 